<!--

File produced by pipelineRunner package (for JATS 2 SCJATS with pipeline SCJATS)
At: 2023-11-28T16:14:23.664Z

Version        : 1.13
Last update    : $LastChangedDate: 2023-08-02 14:53:35 +0100 (Wed, 02 Aug 2023) $
Modified by    : $LastChangedBy: dunnm $

-->
<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="letter"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Brain Commun</journal-id><journal-id journal-id-type="iso-abbrev">Brain Commun</journal-id><journal-id journal-id-type="publisher-id">braincomms</journal-id><journal-title-group><journal-title>Brain Communications</journal-title></journal-title-group><issn pub-type="epub">2632-1297</issn><publisher><publisher-name>Oxford University Press</publisher-name><publisher-loc>US</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">37953838</article-id><article-id pub-id-type="pmc">PMC10639091</article-id><article-id pub-id-type="doi">10.1093/braincomms/fcad297</article-id><article-id pub-id-type="publisher-id">fcad297</article-id><article-categories><subj-group subj-group-type="heading"><subject>Letter to the Editor</subject></subj-group><subj-group subj-group-type="category-taxonomy-collection"><subject>AcademicSubjects/MED00310</subject><subject>AcademicSubjects/SCI01870</subject></subj-group></article-categories><title-group><article-title>Nodding syndrome, populations at risk need to be aware this is a preventable condition</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-1919-1340</contrib-id><name><surname>Colebunders</surname><given-names>Robert</given-names></name><aff>
<institution>Global Health Institute, University of Antwerp</institution>, <addr-line>Antwerp 2610</addr-line>, <country country="BE">Belgium</country></aff><xref rid="fcad297-cor1" ref-type="corresp"/><!--robert.colebunders@uantwerpen.be--></contrib><contrib contrib-type="author"><name><surname>Lakwo</surname><given-names>Thomson</given-names></name><aff>
<institution>Vector Control Division, Ministry of Health</institution>, <addr-line>Kampala</addr-line>, <country country="UG">Uganda</country></aff></contrib><contrib contrib-type="author"><name><surname>Hadermann</surname><given-names>Amber</given-names></name><aff>
<institution>Global Health Institute, University of Antwerp</institution>, <addr-line>Antwerp 2610</addr-line>, <country country="BE">Belgium</country></aff></contrib></contrib-group><author-notes><corresp id="fcad297-cor1">Correspondence to: Robert Colebunders Global Health Institute, University of Antwerp Doornstraat 331, Antwerp 2610, Antwerp, Belgium E-mail: <email>robert.colebunders@uantwerpen.be</email></corresp></author-notes><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub" iso-8601-date="2023-10-28"><day>28</day><month>10</month><year>2023</year></pub-date><pub-date pub-type="pmc-release"><day>28</day><month>10</month><year>2023</year></pub-date><volume>5</volume><issue>6</issue><elocation-id>fcad297</elocation-id><history><date date-type="received"><day>27</day><month>9</month><year>2023</year></date><date date-type="rev-recd"><day>27</day><month>9</month><year>2023</year></date><date date-type="accepted"><day>27</day><month>10</month><year>2023</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2023. Published by Oxford University Press on behalf of the Guarantors of Brain.</copyright-statement><copyright-year>2023</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="fcad297.pdf"/><funding-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>Research Foundation&#x02014;Flanders</institution></institution-wrap>
</funding-source></award-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>FWO</institution><institution-id institution-id-type="DOI">10.13039/501100003130</institution-id></institution-wrap>
</funding-source><award-id>G0A0522N</award-id></award-group></funding-group><counts><page-count count="2"/></counts></article-meta></front><body><p>We were quite surprised to come across the scientific commentary by Spencer titled &#x02018;New clues to the elusive aetiology of nodding syndrome&#x02019;.<sup><xref rid="fcad297-B1" ref-type="bibr">1</xref></sup> Upon reading this commentary, we failed to identify any novel insights; instead, we encountered unjustified arguments refuting the potential causative role of <italic toggle="yes">Onchocerca volvulus</italic> in nodding syndrome.</p><p>We do not understand why, in the same area in South Sudan, the 2001&#x02013;02 study results (very strong association between onchocerciasis and nodding syndrome),<sup><xref rid="fcad297-B2" ref-type="bibr">2</xref></sup> and the 2018&#x02013;19 study results (no association between onchocerciasis and nodding syndrome)<sup><xref rid="fcad297-B3" ref-type="bibr">3</xref></sup> suggest that &#x02018;the nematode infection is a secondary event unrelated to nodding syndrome&#x02019;.<sup><xref rid="fcad297-B1" ref-type="bibr">1</xref></sup> The difference in results of both case-control studies is explained by (i) the re-introduction in 2017 of a community-directed treatment with ivermectin (CDTI) program decreasing the community microfilarial load and (ii) in the 2018&#x02013;19 study more persons with nodding syndrome had taken ivermectin compared with controls.<sup><xref rid="fcad297-B4" ref-type="bibr">4</xref></sup> This could mask the association between onchocerciasis and nodding syndrome. Ivermectin intake should be included in the analysis of any research seeking to discover the aetiology of nodding syndrome.</p><p>One limitation of case-control studies is that it can be challenging to definitively conclude whether a factor is a real risk factor or merely a consequence of the disease. This is particularly difficult in studies on epilepsy as the life of a person with epilepsy especially in South Sudan will change dramatically once seizures develop.<sup><xref rid="fcad297-B5" ref-type="bibr">5</xref></sup> The longer the time from the onset of seizures, the more the biological findings observed at the time of the study; and this will not represent the clinical status of the person with epilepsy before the onset of the seizures. The median age of persons with nodding syndrome in the 2001&#x02013;02 study was 12 years (range 5.0&#x02013;21.0 years)<sup><xref rid="fcad297-B2" ref-type="bibr">2</xref></sup> compared with 15 years (range 9.75&#x02013;17.0 years) in the more recent study.<sup><xref rid="fcad297-B3" ref-type="bibr">3</xref></sup> Therefore, the duration of disease of persons with nodding syndrome included in the 2018&#x02013;19 study was much longer, life changes due to the disease and subsequently increasing the and subsequently increasing probability that &#x02018;suspected nodding syndrome risk factors&#x02019; were perceived as consequences of the disease.</p><p>In the 2018&#x02013;19 study, three potential new risk factors were identified: (i) reduced viral exposures (ii) <italic toggle="yes">Mansonella perstans</italic> infection and (iii) higher levels of vitamins A and E.<sup><xref rid="fcad297-B3" ref-type="bibr">3</xref></sup> We agree that the role of <italic toggle="yes">M. perstans</italic> as a potential co-risk factor for nodding syndrome in South Sudan needs to be further investigated. However, <italic toggle="yes">M. perstans</italic> cannot be a causal factor in nodding syndrome in certain other regions where nodding syndrome has been reported, such as in Mahenge, Tanzania, where <italic toggle="yes">M. perstans</italic> is not endemic.<sup><xref rid="fcad297-B6" ref-type="bibr">6</xref></sup></p><p>In the structural equation model used by Edridge <italic toggle="yes">et al</italic>.,<sup><xref rid="fcad297-B3" ref-type="bibr">3</xref></sup> not only information about the intake of ivermectin and polyvitamins was not available, but also the validity of the model&#x02019;s outcome is questionable. Indeed, it is difficult to understand that fewer viral exposures would be a risk factor for nodding syndrome. It is more likely that it is a consequence of the disease, given that children with nodding syndrome in South Sudan are generally isolated from their peers and most of them are not allowed to attend school.<sup><xref rid="fcad297-B4" ref-type="bibr">4</xref>,<xref rid="fcad297-B7" ref-type="bibr">7</xref></sup> Consequently, they have fewer viral exposures compared with healthy schoolchildren. The increased vitamin A and E levels are more likely to be related to the intake of polyvitamins because of nodding syndrome-related malnourishment. A link to nodding syndrome exposure to cyanobacteria as suggested by Spencer looks far-fetched and not based on epidemiological evidence.<sup><xref rid="fcad297-B1" ref-type="bibr">1</xref></sup></p><p>We noted that the author refers to nodding syndrome as a &#x02018;mysterious disorder&#x02019;.<sup><xref rid="fcad297-B1" ref-type="bibr">1</xref></sup> In recent years, our understanding of nodding syndrome has significantly advanced. Two cohort studies in Cameroon have demonstrated that it is the level of <italic toggle="yes">O. volvulus</italic> microfilarial load in very young children that is a determining factor for developing epilepsy later in life.<sup><xref rid="fcad297-B8" ref-type="bibr">8</xref></sup> Nodding syndrome, along with other forms of onchocerciasis-associated epilepsy (OAE), occurs in areas where onchocerciasis is poorly controlled or without an onchocerciasis control programme. Affected individuals tend to be clustered in villages and households close to blackfly breeding sites.<sup><xref rid="fcad297-B9" ref-type="bibr">9</xref></sup> Moreover, no new nodding syndrome cases appear when onchocerciasis is successfully eliminated.<sup><xref rid="fcad297-B10" ref-type="bibr">10</xref></sup> In his commentary, Spencer states that water sources could play a causal role in nodding syndrome.<sup><xref rid="fcad297-B1" ref-type="bibr">1</xref></sup> However, this is not because of the use of river water for drinking, cooking, handwashing and bathing but because families are living or farming close to blackfly breeding sites putting their children at risk of being repeatedly bitten by <italic toggle="yes">O. volvulus</italic>-infected blackflies. We agree with Spencer that a causative environmental agent should be able to trigger the tau pathology observed in post-mortem studies of nodding syndrome.<sup><xref rid="fcad297-B1" ref-type="bibr">1</xref></sup> However, it is possible that <italic toggle="yes">O. volvulus</italic> microfilaria, secretory/excretory products or endosymbionts, including viruses, could occasionally cross the weakened blood-brain barrier of young children causing neuroinflammation, resulting in epilepsy and tau deposits.<sup><xref rid="fcad297-B10" ref-type="bibr">10</xref></sup></p><p>Evidence-based information about OAE should be disseminated not only to public health policy-makers but also to the affected populations. At the recent 2nd International Workshop on OAE, held from September 19th to 21st in Antwerp, Belgium and organized in collaboration with the WHO Global Onchocerciasis Network for Elimination (GONE) and the WHO Brain Health Unit, recommendations for closer collaboration between the two programmes were proposed. While research concerning the pathogenesis of OAE and the identification of potential causal and protective factors should continue, it was emphasized during this workshop that strengthening of onchocerciasis elimination programmes should be prioritized in areas with high epilepsy prevalence and incidence.<sup><xref rid="fcad297-B10" ref-type="bibr">10</xref></sup> An important part of such a programme should be to increase OAE awareness to motivate populations at risk to take ivermectin in order to prevent children from developing OAE.</p></body><back><sec id="fcad297-s0"><title>Funding</title><p>R.C. received funding from the Fonds voor Wetenschappelijk Onderzoek (FWO), grant number G0A0522N. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.</p></sec><sec sec-type="COI-statement" id="fcad297-s1"><title>Competing interests</title><p>The authors report no competing interests.</p></sec><sec sec-type="data-availability" id="fcad297-s2"><title>Data availability</title><p>Data sharing is not applicable to this article as no new data were created or analysed.</p></sec><ref-list id="ref1"><title>References</title><ref id="fcad297-B1"><label>1</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Spencer</surname> &#x000a0;<given-names>PS</given-names></string-name>
</person-group>. <article-title>New clues to the elusive aetiology of nodding syndrome</article-title>. <source>Brain Commun</source>. <year>2023</year>;<volume>5</volume>(<issue>5</issue>):<fpage>fcad236</fpage>.<pub-id pub-id-type="pmid">37731902</pub-id>
</mixed-citation></ref><ref id="fcad297-B2"><label>2</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Tumwine</surname> &#x000a0;<given-names>JK</given-names></string-name>, <string-name><surname>Vandemaele</surname> &#x000a0;<given-names>K</given-names></string-name>, <string-name><surname>Chungong</surname> &#x000a0;<given-names>S</given-names></string-name>, <etal>et al</etal></person-group> &#x000a0;<article-title>Clinical and epidemiologic characteristics of nodding syndrome in Mundri County, southern Sudan</article-title>. <source>Afr Health Sci</source>. <year>2012</year>;<volume>12</volume>(<issue>3</issue>):<fpage>242</fpage>&#x02013;<lpage>248</lpage>.<pub-id pub-id-type="pmid">23382736</pub-id>
</mixed-citation></ref><ref id="fcad297-B3"><label>3</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Edridge</surname> &#x000a0;<given-names>AWD</given-names></string-name>, <string-name><surname>Abd-Elfarag</surname> &#x000a0;<given-names>G</given-names></string-name>, <string-name><surname>Deijs</surname> &#x000a0;<given-names>M</given-names></string-name>, <etal>et al</etal></person-group> &#x000a0;<article-title>Parasitic, bacterial, viral, immune-mediated, metabolic and nutritional factors associated with nodding syndrome</article-title>. <source>Brain Commun</source>. <year>2023</year>;<volume>5</volume>(<issue>5</issue>):<fpage>fcad223</fpage>.<pub-id pub-id-type="pmid">37731906</pub-id>
</mixed-citation></ref><ref id="fcad297-B4"><label>4</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Abd-Elfarag</surname> &#x000a0;<given-names>GOE</given-names></string-name>, <string-name><surname>Mathewson</surname> &#x000a0;<given-names>JD</given-names></string-name>, <string-name><surname>Emmanuel</surname> &#x000a0;<given-names>L</given-names></string-name>, <etal>et al</etal></person-group> &#x000a0;<article-title>Nodding syndrome: Clinical characteristics, risks factors, access to treatment, and perceptions in the Greater Mundri area, South Sudan</article-title>. <source>Pathogens</source>. <year>2023</year>;<volume>12</volume>(<issue>2</issue>):<fpage>190</fpage>.<pub-id pub-id-type="pmid">36839462</pub-id>
</mixed-citation></ref><ref id="fcad297-B5"><label>5</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Jada</surname> &#x000a0;<given-names>SR</given-names></string-name>, <string-name><surname>Siewe Fodjo</surname> &#x000a0;<given-names>JN</given-names></string-name>, <string-name><surname>Abd-Elfarag</surname> &#x000a0;<given-names>G</given-names></string-name>, <etal>et al</etal></person-group> &#x000a0;<article-title>Epilepsy-related stigma and cost in two onchocerciasis-endemic areas in South Sudan: A pilot descriptive study</article-title>. <source>Seizure</source>. <year>2020</year>;<volume>81</volume>:<fpage>151</fpage>&#x02013;<lpage>156</lpage>.<pub-id pub-id-type="pmid">32810838</pub-id>
</mixed-citation></ref><ref id="fcad297-B6"><label>6</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Amaral</surname> &#x000a0;<given-names>LJ</given-names></string-name>, <string-name><surname>Bhwana</surname> &#x000a0;<given-names>D</given-names></string-name>, <string-name><surname>Mhina</surname> &#x000a0;<given-names>AD</given-names></string-name>, <etal>et al</etal></person-group> &#x000a0;<article-title>Nodding syndrome, a case-control study in Mahenge, Tanzania: <italic toggle="yes">Onchocerca volvulus</italic> and not <italic toggle="yes">Mansonella perstans</italic> as a risk factor</article-title>. <source>PLoS Negl Trop Dis</source>. <year>2023</year>;<volume>17</volume>(<issue>6</issue>):<fpage>e0011434</fpage>.<pub-id pub-id-type="pmid">37339148</pub-id>
</mixed-citation></ref><ref id="fcad297-B7"><label>7</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Jada</surname> &#x000a0;<given-names>SR</given-names></string-name>, <string-name><surname>Tionga</surname> &#x000a0;<given-names>MS</given-names></string-name>, <string-name><surname>Siewe Fodjo</surname> &#x000a0;<given-names>JN</given-names></string-name>, <etal>et al</etal></person-group> &#x000a0;<article-title>Community perception of epilepsy and its treatment in onchocerciasis-endemic villages of Maridi county, western equatoria state, South Sudan</article-title>. <source>Epilepsy Behav</source>. <year>2022</year>;<volume>127</volume>:<fpage>108537</fpage>.<pub-id pub-id-type="pmid">35026562</pub-id>
</mixed-citation></ref><ref id="fcad297-B8"><label>8</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Chesnais</surname> &#x000a0;<given-names>CB</given-names></string-name>, <string-name><surname>Bizet</surname> &#x000a0;<given-names>C</given-names></string-name>, <string-name><surname>Campillo</surname> &#x000a0;<given-names>JT</given-names></string-name>, <etal>et al</etal></person-group> &#x000a0;<article-title>A second population-based cohort study in Cameroon confirms the temporal relationship between onchocerciasis and epilepsy</article-title>. <source>Open Forum Infect Dis</source>. <year>2020</year>;<volume>7</volume>(<issue>6</issue>):<fpage>ofaa206</fpage>.<pub-id pub-id-type="pmid">32587878</pub-id>
</mixed-citation></ref><ref id="fcad297-B9"><label>9</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Lakwo</surname> &#x000a0;<given-names>TL</given-names></string-name>, <string-name><surname>Raimon</surname> &#x000a0;<given-names>S</given-names></string-name>, <string-name><surname>Tionga</surname> &#x000a0;<given-names>M</given-names></string-name>, <etal>et al</etal></person-group> &#x000a0;<article-title>The role of the Maridi dam in causing an onchocerciasis-associated epilepsy epidemic in Maridi, South Sudan: An epidemiological, sociological, and entomological study</article-title>. <source>Pathogens</source>. <year>2020</year>;<volume>9</volume>(<issue>4</issue>):<fpage>315</fpage>.<pub-id pub-id-type="pmid">32344586</pub-id>
</mixed-citation></ref><ref id="fcad297-B10"><label>10</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Colebunders</surname> &#x000a0;<given-names>R</given-names></string-name>, <string-name><surname>Hadermann</surname> &#x000a0;<given-names>A</given-names></string-name>, <string-name><surname>Siewe Fodjo</surname> &#x000a0;<given-names>JN</given-names></string-name></person-group>. <article-title>The onchocerciasis hypothesis of nodding syndrome</article-title>. <source>PLoS Negl Trop Dis</source>. <year>2023</year>;<volume>17</volume>(<issue>8</issue>):<fpage>e0011523</fpage>.<pub-id pub-id-type="pmid">37590176</pub-id>
</mixed-citation></ref></ref-list></back></article>
